Gestational diabetes mellitus: Why the controversy?

Clinical Chemistry

Volumn 64, Issue 3, 2018, Pages 431-438

  Sacks, David B ^a   Coustan, Donald R ^b   Cundy, Tim ^c   Donovan, Lois ^d,e   Hod, Moshe ^f  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF CALGARY   (Canada)

^e ALBERTA HEALTH SERVICES   (Canada)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

CLINICAL PRACTICE; ENDOCRINOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MEDICAL SOCIETY; NOTE; ORAL GLUCOSE TOLERANCE TEST; PERINATAL CARE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; SCREENING; ANALYSIS; FEMALE; GESTATIONAL WEIGHT GAIN; MASS SCREENING; PRACTICE GUIDELINE; PREGNANCY; RISK FACTOR; UNITED STATES;

BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL WEIGHT GAIN; GLUCOSE TOLERANCE TEST; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RISK FACTORS; UNITED STATES;

EID: 85042706862     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.266577     Document Type: Note

References (0)